Addison's Disease at Labor: When to Start Parenteral Stress-Dose Coverage
A single patient whose antepartum adrenal management has gone smoothly, now facing labor itself — a real stressor whose duration and course can't be known in advance.
Delphine A., a 33-year-old physical therapist, has autoimmune Addison's disease diagnosed nine years ago and is now thirty-eight weeks into a pregnancy that has, medically, been unremarkable — her hydrocortisone dose was increased by roughly 30% starting at week twenty-four per her endocrinologist's standard practice, tracking the well-documented physiologic rise in cortisol demand through pregnancy, and her labs have stayed appropriately controlled since. She has spent the last several appointments asking detailed, specific questions about the delivery plan itself, a habit her endocrinologist recognizes from her own clinical work — Delphine treats patients who've had joint replacements and knows, better than most first-time mothers, how much a plan on paper can diverge from what actually happens in a procedure room. What's now in front of the team is the labor and delivery plan itself, and it's a genuinely different problem than antepartum dosing: labor is a real, if variable-duration, physiologic stressor, but nobody can say in advance whether Delphine's labor will be six hours or twenty-six, or whether it ends in vaginal delivery or an unplanned cesarean partway through — each of which implies a different stress-dose trajectory under standard perioperative and illness-based frameworks that weren't written with labor's own unpredictable arc in mind.
The obstetric anesthesia literature on this specific scenario is thinner than either general stress-dosing or general pregnancy-adjustment guidance alone, largely because primary adrenal insufficiency in pregnancy is rare enough that no large trial has ever specifically tested a labor stress-dose protocol against alternatives. What exists is the 2016 Endocrine Society guideline's recommendation (Bornstein et al.) that labor be stress-dosed like major surgical stress, which is itself convention built by extrapolation rather than trial evidence — active labor treated roughly like moderate-to-major physiologic stress, with parenteral hydrocortisone through labor and delivery, then rapidly tapered over the following days as she returns to her established pregnancy dose and eventually her pre-pregnancy baseline.
Obstetric planning conference, 38 weeks
Labor's duration and course aren't predictable in advance, and by the time an ordinary-looking labor turns into something harder, we may already be behind on coverage. I'd start parenteral hydrocortisone at the onset of active labor regardless of how it looks at the start, and taper afterward once she's stable.
Most labors, including what we'd expect for her, proceed within a range her already-increased pregnancy dose is built to handle. I'd rather not put every laboring patient with adrenal insufficiency on parenteral steroids by default — that overtreats the typical case to guard against an atypical one that may not happen. I'd continue her oral dose through early labor and reserve parenteral dosing for if labor becomes prolonged or a cesarean is called.
Then say what the default costs. Every laboring patient with adrenal insufficiency gets a line, gets parenteral steroid, and gets whatever hyperglycemia comes with it — including the majority whose labor never leaves the range her current dose already covers. That is a real price, paid by real patients, to insure against a scenario that mostly doesn't happen.
This is exactly the kind of situation labor and delivery units are built to handle without picking one extreme in advance. Keep her on oral dosing through early labor, but have parenteral hydrocortisone drawn up and sitting with her chart from admission, with a clear, written trigger — prolonged labor, active pushing, or a cesarean called — so it's given the moment one of those happens, not preemptively and not with any delay once it's actually needed.
Agreed: continue oral hydrocortisone through early labor, with parenteral hydrocortisone drawn up and given immediately if labor becomes prolonged, active pushing begins, or a cesarean is called, followed by a rapid post-delivery taper. All three voices endorsed this specific plan.
The team also settled on a working definition of "prolonged" for the trigger — active labor extending beyond twelve hours — after brief discussion; this was a detail to pin down together, not a real disagreement about the underlying approach.